Characterization of miRNA expression profiles and their potential targets upon Bz and Bz + PTX therapy in chronically infected mice. Relative expression was expressed as fold change (2^-ΔΔCt). miRNAs with a fold change greater than 1.3 in the vehicle group and at the 0.75–1.3 range (orange striped area) in the Bz and Bz + PTX therapy groups were considered to have a restored expression. They were selected for further analysis on IPA software. (A) The expression of miRNAs was altered in the infected group and an expression was restored after Bz therapy. (B) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (C) Diseases and disorders pathway analysis. (D) The expression of miRNAs was altered in the infected group and restored upon Bz + PTX therapy. (E) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (F) Diseases and disorders pathway analysis. Significant intervals by Glaucia Vilar-Pereira (686134)

“…(E) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (F) Diseases and disorders pathway analysis. Significant intervals</p>…”

Final global negative binomial model showing significant predictors of COVID-19 risk in the Greater St. Louis Area, Missouri (USA). by Praachi Das (13876574)

STAT6 siRNA sequences 1 and 4 significantly reduce cell proliferation. by Carmen Salguero-Aranda (6690044)

The reduced virulence of Δalta1 mutants is not primarily due to a decrease in growth. by Shuhuan Zhang (748003)

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Number of significantly significant (P < 0.05) differentially abundant (SSDA) proteins showing increased or decreased activity (fold change +/- 1.5-fold) relative to time 0 followi... by Peter E. Lillis (12368582)

Quiescent amastigotes exhibit a significantly reduced size compared to DsRed^hi amastigotes. by Laura Dirkx (8950205)

Drug-induced decrease of cell anisotropy reduces pattern fidelity. by Camille Curantz (7456499)

“…<b>(B)</b> Quantifications of primordia spacing variability on phalloïdin-stained control flat skins (explant; triangles) and LatA-treated cultured explants (+LatA; squares) of Japanese quail embryos showed that LatA treatment caused a significant decrease in pattern fidelity at condensation stage (explants, <i>n</i> = 9; +LatA, <i>n</i> = 9; unpaired 2-tailed <i>t</i> test; <i>p</i> = 0.0233) and differentiation stage (explants, <i>n</i> = 8; +LatA, <i>n</i> = 9; <i>p</i> = 0.002). …”

The variation trend of |BD| value with age: With the increase of age, the |BD| values decreased significantly (p<0.01). by Yunmeng Da (707943)

Conditions that ablate cytonemes decrease signaling, reduce myoblast and tumor growth. by Sol Fereres (664350)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

Geniposide (Gen) significantly decreased the content of Hyp in bleomycin-induced PF mice’s lung tissue. by Jian-Bin Yin (19556105)

Western blot comparing markers of DNA repair. by Rachael Guenter (15147776)

Subjects:

Variants with an unknown significance or conflicting interpretation of clinical significance. by J. Tyson McDonald (3687694)

Subjects:

Energy efficiency variation across cities in the Greater Bay Area. by YanFei Lei (19532983)

Subjects:

EF-24 treatment significantly reduces cell viability in leukemia cell lines. by Ajeet P. Singh (22298432)

Subjects:

Both MRI and SR-PCI demonstrated significant decreases in clinically-relevant articular cartilage parameters. by Suranjan Bairagi (17087667)

Combination treatment reduces cell viability and induces apoptosis in TOM-1 cells and both drug combined do not antagonize each other. by Saskia Maletzke (13003764)

Subjects: